Jean-Luc Diehl to Biomarkers
This is a "connection" page, showing publications Jean-Luc Diehl has written about Biomarkers.
Connection Strength
0.128
-
Angiopoietin-2 as a marker of endothelial activation is a good predictor factor for intensive care unit admission of COVID-19 patients. Angiogenesis. 2020 11; 23(4):611-620.
Score: 0.040
-
Circulating biomarkers may be unable to detect infection at the early phase of sepsis in ICU patients: the CAPTAIN prospective multicenter cohort study. Intensive Care Med. 2018 07; 44(7):1061-1070.
Score: 0.035
-
Immune Signature Linked to COVID-19 Severity: A SARS-Score for Personalized Medicine. Front Immunol. 2021; 12:701273.
Score: 0.011
-
Differential association between inflammatory cytokines and multiorgan dysfunction in COVID-19 patients with obesity. PLoS One. 2021; 16(5):e0252026.
Score: 0.011
-
Placental growth factor level in plasma predicts COVID-19 severity and in-hospital mortality. J Thromb Haemost. 2021 07; 19(7):1823-1830.
Score: 0.011
-
Von Willebrand factor collagen-binding capacity predicts in-hospital mortality in COVID-19 patients: insight from VWF/ADAMTS13 ratio imbalance. Angiogenesis. 2021 08; 24(3):407-411.
Score: 0.011
-
Circulating Von Willebrand factor and high molecular weight multimers as markers of endothelial injury predict COVID-19 in-hospital mortality. Angiogenesis. 2021 08; 24(3):505-517.
Score: 0.010